{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:46:54Z","timestamp":1788281214428,"version":"build-2803163510"},"reference-count":17,"publisher":"Japan Neurosurgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2025,1,15]]},"DOI":"10.2176\/jns-nmc.2024-0204","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T17:11:37Z","timestamp":1732468297000},"page":"29-36","source":"Crossref","is-referenced-by-count":16,"title":["Impact of Clazosentan on Vasospasm Reduction and Functional Recovery after Aneurysmal Subarachnoid Hemorrhage"],"prefix":"10.2176","volume":"65","author":[{"given":"Sosho","family":"KAJIWARA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Kurume University School of Medicine"},{"name":"Department of Neurosurgery, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"KAWANO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"HASEGAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kurume University School of Medicine"},{"name":"Department of Pharmaceutical Sciences, School of Pharmacy at Fukuoka, International University of Health and Welfare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"NAKAMURA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiko","family":"SAKATA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"KIKUCHI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"HIROHATA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"MORIOKA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Tomassoni D, Lanari A, Silvestrelli G, Traini E, Amenta F: Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. <i>Clin Exp Hypertens<\/i> 2008: 30: 744-766","DOI":"10.1080\/10641960802580232"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Schwarting J, Harapan BN, Lin X, Plesnila N, Terpolilli NA: Nimodipine reduces micro vasospasms after experimental subarachnoid hemorrhage. <i>Stroke<\/i> 2023: 54: 2666-2670","DOI":"10.1161\/STROKEAHA.123.043976"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Narayan V, Shukla D, Bhat DI, Prabhuraj AR, Devi BI: Ozagrel for postoperative management of aneurysmal subarachnoid hemorrhages. <i>Neurol India<\/i> 2019: 67: 1286-1289","DOI":"10.4103\/0028-3886.271236"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nakashima S, Tabuchi K, Shimokawa S, Fukuyama K, Mineta T, Abe M: Combination therapy of fasudil hydrochloride and ozagrel sodium for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. <i>Neurol Med Chir (Tokyo)<\/i> 1998: 38: 805-810","DOI":"10.2176\/nmc.38.805"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Liu W, Gao J, Yi X, Li Y, Zeng Y: Absorption, tissue disposition, and excretion of fasudil hydrochloride, a RHO kinase inhibitor, in rats and dogs. <i>Biopharm Drug Dispos<\/i> 2020: 41: 206-220","DOI":"10.1002\/bdd.2231"},{"key":"6","unstructured":"6) Ye H, Liu Z, Zhou L, Cai Q: Effect of nimodipine combined with fasudil on vascular endothelial function and inflammatory factors in patients with cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. <i>Am J Transl Res<\/i> 2022: 14: 2617-2624"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Li K, Barras CD, Chandra RV, et al.: A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. <i>World Neurosurg<\/i> 2019: 126: 513-527","DOI":"10.1016\/j.wneu.2019.03.083"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Dorsch NW, King MT: A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage part I: incidence and effects. <i>J Clin Neurosci<\/i> 1994: 1: 19-26","DOI":"10.1016\/0967-5868(94)90005-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) de Oliveira JG, Beck J, Ulrich C, Rathert J, Raabe A, Seifert V: Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. <i>Neurosurg Rev<\/i> 2007: 30: 22-31","DOI":"10.1007\/s10143-006-0045-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yanagisawa M, Kurihara H, Kimura S, et al.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. <i>Nature<\/i> 1988: 332: 411-415","DOI":"10.1038\/332411a0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Macdonald RL, Kassell NF, Mayer S, et al.: Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. <i>Stroke<\/i> 2008: 39: 3015-3021","DOI":"10.1161\/STROKEAHA.108.519942"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Macdonald RL, Higashida RT, Keller E, et al.: Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). <i>Lancet Neurol<\/i> 2011: 10: 618-625","DOI":"10.1016\/S1474-4422(11)70108-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Macdonald RL, Higashida RT, Keller E, et al.: Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. <i>Stroke<\/i> 2012: 43: 1463-1469","DOI":"10.1161\/STROKEAHA.111.648980"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T: Effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients. <i>Cerebrovasc Dis<\/i> 2017: 44: 59-67","DOI":"10.1159\/000475824"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Endo H, Hagihara Y, Kimura N, et al.: Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. <i>J Neurosurg<\/i> 2022: 137: 1707-1717","DOI":"10.3171\/2022.2.JNS212914"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Sakata H, Kanoke A, Uchida H, et al.: Prophylactic management of cerebral vasospasm with clazosentan in real clinical practice: a single-center retrospective cohort study. <i>Front Neurol<\/i> 2024: 15: 1413632","DOI":"10.3389\/fneur.2024.1413632"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Mochizuki T, Ryu B, Shima S, et al.: Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients: a single-center experience in Japan. <i>Neurosurg Rev<\/i> 2024: 47: 113","DOI":"10.1007\/s10143-024-02345-9"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/65\/1\/65_2024-0204\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T23:30:34Z","timestamp":1737156634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/65\/1\/65_2024-0204\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2024-0204","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"2024-0204"}}